The latest gross profit for SYNH is $3.3B as of June 2023. That compares with $5.4B in the prior-year period — down 39.9% year over year. That is below the Healthcare sector average of $66B. Investors often review this figure alongside Syneos Health's historical trend and sector peers before judging valuation or financial health.

Over the past year, SYNH's gross profit moved from $5.4B to $3.3B — a 39.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Syneos Health's operating scale or balance-sheet position.

Against Healthcare companies, SYNH currently prints $3.3B for gross profit, while the sector average sits near $66B. That is roughly 95.1% below the sector mean. Large gaps often invite a closer look at Syneos Health's growth, margins, and balance sheet.

A gross profit figure of $3.3B for SYNH is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $66B. Explore the charts below for those layers of context.

After noting SYNH's gross profit ($3.3B), review year-over-year change from $5.4B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.